跳至主要内容
临床试验/IRCT2013112915581N1
IRCT2013112915581N1已完成2 期

Evaluation of adding vitamin D to standard HCV regimen(PEG-interferon plus ribaverin) on early virologic response(EVR)

Vice chancellor for research, Mashhad University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Major criteria to include in the study: The patients with hepatitis C who had not been under therapy were included in the study.
  • Major criteria to exclude from the study: HIV patients; concurrent infection with hepatitis B and D; alcohol abuse; Wilson’s disease; hemochromatosis; decompensated cirrhosis, child score>9; patients with hepatocellular carcinoma; previous hepatitis C treatment; chronic kidney disorder; using antiepileptic drugs; history of vitamin D consumption (in the control group); pregnancy or breastfeeding; and steroid consumption.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Mashhad University of Medical Sciences

相似试验